Genzyme to acquire Wyntek

GENZ will acquire Wyntek (San Diego, Calif.), a developer of point-of-care diagnostics, for $65 million in cash. Wyntek posted $17.5 million in sales of its rapid tests in 2000, which GENZ expects wil...